• 제목/요약/키워드: hemodialysis membrane

검색결과 12건 처리시간 0.022초

혈액투석막의 최근 연구 동향: 리뷰 (Recent Progress in Hemodialysis Membrane: A Review)

  • 가야트리 바미디파티;라즈쿠마 파텔
    • 멤브레인
    • /
    • 제34권2호
    • /
    • pp.105-113
    • /
    • 2024
  • 만성 콩팥병은 많은 사람들이 말기병으로 진단받고 있다. 이 질병은 혈액이 막과 투석기에 의해 세척되는 과정인 혈액투석에 의해 치료된다. 혈액투석을 위한 막은 혈액에서 불순물인 요소를 선택적으로 제거하는 역할을 하기 때문에 이 과정은 중요한 첫 단계이다. 다양한 종류의 고분자로 구성된 막이 사용되지만, 낮은 선택도와 혈액적합성과 같은 다양한 단점을 가지고 있다. 이를 해결하기 위해 여러 논문에서 서로 다른 고분자의 혼합물을 사용하여 기공의 크기를 변화시키고 혈액적합성을 높이며 선택성을 높이는 연구를 진행하였다. 그동안 보고된 논문들을 통해 혼합막이 더 큰 장점을 가지고 있음을 알 수 있었다.

Bolld Compatibility of Cellulose Membrane with Phosphonolipid Polar Groups

  • Lee, M.K.;Kim, M.S.;Jung, S.K.;Park, S.M.
    • 한국막학회:학술대회논문집
    • /
    • 한국막학회 1994년도 추계 총회 및 학술발표회
    • /
    • pp.14-16
    • /
    • 1994
  • Requirements for the hemodialysis membrane are excellent permeability for water and solute, mechanical strength and blood compatibility. Many synthetic polymer membranes have been invertigated to raise the efficiency of dialysis, however, 85% of the worldwide hemodialysis still uses cellulose membrane. Though the cellulose membrane has both good permeability and mechenical properties, its blood compatibility needs to be improved for hemodialysis. In this paper, 2-(methacryloyloxy)ethyl-2-(trimethyl ammonium) ethyl phosphate(MTP) and Glycidylmethacrylate(GMA) were grafted on the cellulose membranes to make blood compa- tible membranes.

  • PDF

독성 물질 제거에 있어서 투석과 연관된 치료 (Dialysis Related Treatment to Increase Elimination of Toxic Agent)

  • 김흥수;신규태
    • 대한임상독성학회지
    • /
    • 제1권1호
    • /
    • pp.6-11
    • /
    • 2003
  • Various forms of dialytic techniques are available for detoxification. Hemodialysis, hemoperfusion and hemofiltration (hemodialfiltration) are the main treatment modalities. Because these modalities are rather invasive and expensive, it must be decided in balance of the risk and benefit to the patient. The prime consideration in the decision is based on the clinical features of poisoning; hemodialysis or hemoperfusion should be considered in general if the patient's condition progressively deteriorates despite intensive supportive therapy. The hemodialysis technique relies on passage of the toxic agent through a semipermeable membrane so that it can equilibrate with the dialysate and subsequently removed. It needs a blood pump to pass blood next to a dialysis membrane, which allows agents permeable to the membrane to pass through and reach equilibrium. Solute (or drug) removal by dialysis has numerous determinants such as solute size, its lipid solubility, the degree to which it is protein bound, its volume of distribution etc. The technique of hemoperfusion is similar to hemodialysis except there is no dialysis membrane or dialysate involved in the procedure. The patient's blood is pumped through a perfusion cartridge, where it is in direct contact with adsorptive material (usually activated charcoal) that has a coating material such as cellulose. This method can be used successfully with lipid-soluble compounds and with higher-molecular-weight compounds than for hemodialysis. Protein binding does not significantly interfere with removal by hemoperfusion. In conclusion, hemodialysis, hemoperfusion and hemofiltration can be used effectively as adjuncts to the management of severely intoxicated patients.

  • PDF

History of Membrane Development and Mass Tranfer Modelling

  • Matsuura, Takeshi
    • 한국막학회:학술대회논문집
    • /
    • 한국막학회 1996년도 제4회 하계분리막 Workshop (초순수 제조와 막분리 공정)
    • /
    • pp.33-89
    • /
    • 1996
  • History of Membrane Process Development 1920 : microfiltration : Zsigmondy 1930 : ultrafiltration 1950 : hemodialysis : Kolff 1955 : electrodialysis 1960 : reverse osmosis : Loeb, sourirajan 1960 : ultrafiltration 1979 : gas separation : Henis, Tripodi 1982 : pervaporation : Tusel

  • PDF

인공신에 의한 백혈구 수의 변화 혈장 및 알부민의 전처치가 이에 미치는 영향 (The Effect of Cuprophane Hemodialyzer Treated with Plasma and Albumin on Leukocyte Count)

  • 장현규;박찬현
    • 대한의용생체공학회:의공학회지
    • /
    • 제8권2호
    • /
    • pp.241-244
    • /
    • 1987
  • It is now well established that transient granulocytopenia is common in patients during the initial phase of hemodialysis with new cuprophane membrane, but not with reused nembrane, or some synthetic membranes. In this study, new cuprophane dialyzer was treated with plasma and albumin, respectively, then, peripheral blood leukocytes were counted at the onset and after 15 minute of hemodialysis. In the plasma-treated group, the percent of leukopenia was less (41.3 %) than control group (71.3 %). In the plasmatreated group, the degree of leukopenia was close to that ot'control grou p. The protective factor, therefore is thought to be present in the plasma other than albumin fraction.

  • PDF

혈장내 염의 Poly(2-Hydroxyethyl Methacrylate) 격막 투과현상 (Transport of Some Solutes in Blood Plasma Through Poly(2-Hydroxyethyl Methacrylate) Hydrogel Membrane)

  • 지종기;전무식;이태규
    • 대한화학회지
    • /
    • 제22권5호
    • /
    • pp.304-310
    • /
    • 1978
  • 혈장내의 중요한 성분인 몇가지 염들이 poly(2-hydroxyethyl methacrylate) 격막을 통과하는 상대투과계수($U_{re}$), 분배계수($K_D$), 확산계수($D_m$)등을 측정하였다. 이 격막을 제조할 때 cross-linker로서 사용된 tetraethylene glycol dimethacrylate(TEGDMA)의 함량은 중량비로 2.8%였다. 이 염들의 확산계수는 그 분자량이 증가함에 따라서 지수함수적으로 감소하였으며, 그 분자의 원통반지름(a)에 대해서는 요소를 제외하고는 직선적으로 감소하였다. 이와 같은 사실을 sieve pore filow 모델로서 설명하였다. 여러 온도에서 요소의 $U_{re}$$D_m$은 글리신, ${\beta}$-알라닌, D-글루코오스, 사카로스 및 말레산과 같은 다른 염들의 값보다 더 컸다. 이와 같은 결과는 이 poly(HEMA) 격막이 혈투석 응용에 적합하다는 사실을 보여 주었다.

  • PDF

정상 신기능을 보인 Goodpasture 증후군 1예 (A Case of Goodpasture's Syndrome with Normal Renal Function)

  • 김성경;이진국;주겨레;허성은;김정훈;김영균;이숙영;김승준;김치홍;송소향;박성학;최영진
    • Tuberculosis and Respiratory Diseases
    • /
    • 제59권1호
    • /
    • pp.86-92
    • /
    • 2005
  • Goodpasture's syndrome is a disease that is characterized by hemoptysis, anemia, and glomerulonephritis with renal failure. Goodpasture reported a case of a young man who expired as a result of a pulmonary hemorrhage and glomerulonephritis at the recovery phase after an influenza infection in 1919. In 1958, Stanton et al. described a combined case of these two diseases as Goodpasture's syndrome. Since then, antiglomerular basement membrane antibody(anti-GBM Ab) has been confirmed to play an important role in the mechanism of this syndrome, and it was reported that this syndrome was an autoimmune disease. The triad of alveolar hemorrhage, glomerulonephritis and circulating anti-GBM Ab forms the basis of a diagnosis of Goodpasture's syndrome. When patients are affected by disease, the relief of symptoms can be accomplished by eliminating the anti-GBM Ab from the circulatory system through hemodialysis, plasmapheresis and immunoabsorption. However, the patients usually die from a massive pulmonary hemorrhage when the diagnosis or treatment is delayed. The incidence of Goodpasture's syndrome is common in the western world, but it is extremely rare in Korea with only five cases being reported. In three of these cases, pulmonary hemorrhage and renal failure was the initial manifestation. Therefore, hemodialysis or plasmapheresis were absolutely essential treatments. We report a case of Goodpasture's syndrome in Korea with a normal renal function.

Plasma Protein Adsorption to Anion Substituted Poly(vinyl alcohol) Membranes

  • Ryu, Kyu-Eun;Hyangshuk Rhim;Park, Chong-Won;Chun, Heung-Jae;Hong, Seung-Hwa;Kim, Jae-Jin;Lee, Young-Moo
    • Macromolecular Research
    • /
    • 제11권6호
    • /
    • pp.451-457
    • /
    • 2003
  • Anion-substituted poly(vinyl alcohol) (PVA) membranes, carboxymethylated PVA (C-PVA), and sulfonated PVA (S-PVA) were prepared and the effects of these substitutions on the plasma protein adsorption were studied by one- and two-dimensional gel electrophoresis and immunoblotting. When Cuprophane was used as a negative control, the amount of total proteins bound to samples decreased in the order Cuprophane > PVA > C-PVA > S-PVA, which we attribute to the effects of the surface characteristics of the samples, such as their surface tensions and electrostatic properties, on the adsorption of proteins to the surfaces of the materials. The results revealed that albumin was the most abundant protein in all the samples. The proportion of adsorbed fibrinogen to S-PVA exceeded those of PVA and C-PVA, whereas S-PVA exhibited the lowest IgG adsorption affinity among the samples we studied.

Venovenous Extracorporeal Membrane Oxygenation for Postoperative Acute Respiratory Distress Syndrome

  • Seo, Dong Ju;Yoo, Jae Suk;Kim, Joon Bum;Jung, Sung-Ho;Choo, Suk Jung;Chung, Cheol Hyun;Lee, Jae Won
    • Journal of Chest Surgery
    • /
    • 제48권3호
    • /
    • pp.180-186
    • /
    • 2015
  • Background: Extracorporeal membrane oxygenation (ECMO) has recently attracted interest as a treatment for severe acute respiratory distress syndrome (ARDS). However, the outcomes of this procedure in post-surgical settings have not yet been characterized. In this study, we evaluated the outcomes of ECMO in patients with severe postoperative ARDS. Methods: From January 2007 to December 2012, a total of 69 patients (aged $58.3{\pm}11.5$ years, 23 females) who underwent venovenous ECMO to treat severe postoperative ARDS were reviewed. Of these patients, 22 (31.9%) had undergone cardiothoracic surgery, 32 (46.4%) had undergone liver transplantation, and 15 (21.7%) had undergone other procedures. Results: Thirty-four patients (49.3%) were successfully weaned from ECMO, while the other 35 patients (50.7%) died on ECMO support. Among the 34 patients who were successfully weaned from ECMO, 21 patients (30.4%) eventually died before discharge from the hospital, resulting in 13 hospital survivors (18.8%). Multivariable analysis showed that the duration of pre-ECMO ventilation was a significant independent predictor of death (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.29 to 3.90; p=0.004), whereas the concomitant use of continuous venovenous hemodialysis (CVVHD) was associated with improved survival (OR, 0.55; 95% CI, 0.31 to 0.97; p=0.038). Conclusion: Although the overall survival rate of patients treated with ECMO for postoperative ARDS was unfavorable, ECMO offered an invaluable opportunity for survival to patients who would not have been expected to survive using conventional therapy. CVVHD may be beneficial in improving the outcomes of such patients, whereas a prolonged duration of pre-ECMO ventilator support was associated with poor survival.

마이크로 플루이딕 칩을 기반으로 한 크레아티닌 여과장치 (A Microfluidic Chip-Based Creatinine Filtration Device)

  • 이삭;신동규;응웬탄콰;박우태
    • 대한기계학회논문집B
    • /
    • 제39권12호
    • /
    • pp.921-925
    • /
    • 2015
  • 매년마다 신장질환으로 고통 받는 사람들이 증가하는 추세이다. 가장 흔한 치료법 중 하나는 혈액 투석인데, 이 방법은 많은 시간이 걸리고, 비용이 많이 드는 방법이다. 이러한 이유 때문에, 인공신장 연구의 중요성이 대두되고 있다. 혈액에서 크레아티닌을 여과하는 것은 신장의 주요 기능 중 하나이다. 우리는 이 기능에 초점을 맞춘 새로운 2 채널 마이크로 플루이딕 칩을 고안하였다. 두 개의 PDMS 층을 결합하기 위하여, 아크릴을 가공한 하우징 시스템이 개발하였으며, 이 방법은 여과막을 쉽게 바꿀 수 있다는 이점이 있다. 우리는 알루미늄 양극 산화물(AAO)을 여과막으로 사용하였다. 여과된 용액은 자페반응(Jaffe reation)을 이용하여, 크레아티닌 농도별 흡광도 차이를 분석하였다. 크레아티닌의 양에 대한 표준식을 만들어, 측정한 데이터를 보간하여 여과된 용액의 농도를 확인하였다. 실험을 통하여 유량 및 크레아티닌 농도에 따른 여과율을 얻을 수 있었다.